Hideki Garren - Jan 1, 2024 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Director
Signature
/s/ David Snyder, Attorney-in-Fact
Stock symbol
COYA
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
4
Date filed
1/19/2024, 06:30 PM
Previous filing
Sep 13, 2023
Next filing
Feb 29, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award $0 +5K $0.00 5K Jan 1, 2024 Common Stock, par value $0.0001 per share 5K $7.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.